An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment

NACompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

July 19, 2017

Primary Completion Date

January 10, 2020

Study Completion Date

December 31, 2020

Conditions
TuberculosisDrug-resistant TuberculosisAdherence, MedicationAdherence, Patient
Interventions
OTHER

Electronic DOT

"Electronic DOT is the use of electronic communication methods to observe patients swallow anti-TB drugs and monitor for medication side effects. This study will use two variations of electronic communication methods, referred to as electronic directly observed therapy or eDOT. This includes: (1) eDOT conducted live in which TB program staff interact with patients via a computer or phone application as they ingest their medication (eDOT-live), and (2) eDOT conducted using time stamped, recorded videos in which TB program staff log into an electronic system and review videos recorded by patients in order to verify that patients ingested their medication doses as scheduled (eDOT-recorded)."

OTHER

In-person DOT

A trained person is in the physical presence of patients as anti-TB drugs are ingested.

Trial Locations (4)

10032

Washington Heights Chest Center, New York

10456

Morrisania Chest Center, The Bronx

11201

Fort Greene Chest Center, Brooklyn

11372

Corona Chest Center, Jackson Heights

All Listed Sponsors
collaborator

New York City Department of Health and Mental Hygiene

OTHER_GOV

collaborator

Columbia University

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT03266003 - An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment | Biotech Hunter | Biotech Hunter